In addition to ARHR2 and GACI, patients with a pathogenic variant in ENPP1 gene can exhibit hearing loss, OPLL, PXE, and thrombocytopenia, hypoglycemia, neurologic or hepatic manifestations (4–6, 11, 23, 24). This evidence concerns the gene ENPP1 and Hypoglycemia.